- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Salarius Pharmaceuticals (NASDAQ:SLRX), Quotes and News Summary
Salarius Pharmaceuticals (NASDAQ: SLRX)
Earnings
see more| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-08-04 | ||||||
| REV | |||||||
| Q1 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.090 | -0.130 | -0.0400 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Salarius Pharmaceuticals Questions & Answers
You can purchase shares of Salarius Pharmaceuticals (NASDAQ: SLRX) through any online brokerage.
Other companies in Salarius Pharmaceuticals’s space includes: Immuron (NASDAQ:IMRN), Midatech Pharma (NASDAQ:MTP), Cyclacel Pharmaceuticals (NASDAQ:CYCC), BioRestorative Therapies (NASDAQ:BRTX) and Geovax Labs (NASDAQ:GOVX).
The latest price target for Salarius Pharmaceuticals (NASDAQ: SLRX) was reported by HC Wainwright & Co. on Friday, March 11, 2022. The analyst firm set a price target for 4.00 expecting SLRX to rise to within 12 months (a possible 1804.76% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Salarius Pharmaceuticals (NASDAQ: SLRX) is $0.21 last updated June 30, 2022, 8:00 PM UTC.
There are no upcoming dividends for Salarius Pharmaceuticals.
Salarius Pharmaceuticals’s Q2 earnings are confirmed for Thursday, August 4, 2022.
There is no upcoming split for Salarius Pharmaceuticals.
Salarius Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.